Auddia's LT350 Secures Non-Binding LOI with NYSE Medical REIT for AI Micro-Datacenter Pilot
Summary
Auddia announced that its LT350 business, which is slated to be part of the new holding company post-merger with Thramann Holdings, has signed a non-binding Letter of Intent (LOI) with a NYSE-listed medical REIT. This LOI outlines a potential pilot installation of LT350's solar-integrated AI micro-datacenter canopy across the REIT's portfolio of approximately 200 medical properties. While non-binding and requiring an estimated 18 months of development post-merger, this represents a positive, albeit early, validation for LT350's technology and a potential future revenue stream. This development offers a positive counterpoint to the recent 10-K and 8-K filings that revealed a going concern warning, zero revenue, and significant shareholder dilution.
At the time of this announcement, AUUD was trading at $0.80 on NASDAQ in the Technology sector, with a market capitalization of approximately $3.1M. The 52-week trading range was $0.66 to $7.29. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.